Apellis price target lowered to $55 from $92 at Baird

Baird lowered the firm’s price target on Apellis (APLS) to $55 from $92 and keeps an Outperform rating on the shares. The firm said they reported 3Q24 results, including a sequentially lower Syfovre revenue quarter on modest vial growth but lower net price and increased competition.